Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
X5 Retail Group may buy Saratov's Grozd chain stores
5/11/23
FIVE
MTS reported for 3 months of 2023 by RAS
5/11/23
MTSS
Beyond Meat reports 3 months of 2023
5/11/23
BYND
Walt Disney reported 6 months of fiscal year 2023
5/11/23
DIS
Rosseti will receive from state shares of regional power grid company RPG
5/11/23
FEES
Seligdar reported for 3 months of 2023 by RAS
5/10/23
SELG
Rusolovo reported for 3 months of 2023 by RAS
5/10/23
ROLO
LSR wants to sell several plots in the south of St. Petersburg
5/10/23
LSRG
Natura Siberica plans to expand its store network by 30% by the summer of 2024
5/10/23
AFKS
Consortium of investors buys Syneos Health
5/10/23
SYNH
«
Previous
618
619
620
621
622
623
624
625
626
627
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)